313348-27-5

313348-27-5 structure

Name: Regadenoson
Chemical Name: Regadenoson
CAS Number: 313348-27-5
Molecular Formula: C₁₅H₁₈N₈O₅
Molecular Weight: 390.354
Catalog: Signaling Pathways GPCR/G Protein Adenosine Receptor
Create Date: 2018-05-23 08:00:00
Modify Date: 2024-01-02 14:12:33
Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator that is commonly used in pharmacologic stress testing.Target: A2A adenosine receptorRegadenoson produces hyperemia quickly and maintains it for a duration that is useful for radionuclide myocardial perfusion imaging. The selective nature of the drug makes it preferable to other stress agents such as adenosine, which are less selective and therefore cause more side-effects.Regadenoson has a 2 to 3 minute biological half-life.[1]

Name	Regadenoson
Synonyms	2-[4-(Methylcarbamoyl)-1H-pyrazol-1-yl]adenosine Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]- Regadenoson Regadenoson anhydrous

Description	Regadenoson is an A2A adenosine receptor agonist that is a coronary vasodilator that is commonly used in pharmacologic stress testing.Target: A2A adenosine receptorRegadenoson produces hyperemia quickly and maintains it for a duration that is useful for radionuclide myocardial perfusion imaging. The selective nature of the drug makes it preferable to other stress agents such as adenosine, which are less selective and therefore cause more side-effects.Regadenoson has a 2 to 3 minute biological half-life.[1]
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Adenosine Receptor Research Areas >> Cardiovascular Disease
References	[1]. Pape M, et al. Safety and tolerability of regadenoson for myocardial perfusion imaging - first Danish experience. Scand Cardiovasc J. 2016 Jun;50(3):180-6.